Skip to content

Effect of Prevention Education in Caries Formation in Pediatric Patients With Leukemia

Effect of Prevention Education on Factors of Importance in Caries Formation in Pediatric Patients With Leukemia

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03281746
Enrollment
2
Registered
2017-09-13
Start date
2017-05-19
Completion date
2018-03-02
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia

Brief summary

This randomized pilot clinical trial studies how well preventive education works in decreasing caries formation in pediatric patients with leukemia. Prevention education may have an effect on factors important in causing cavities in pediatric patients with leukemia.

Detailed description

Patients treated for leukemia at Virginia Commonwealth University Medical Center in the department of Pediatric Hematology and Oncology are currently receiving oral hygiene instruction at diagnosis. In this study, patients will be randomized into two groups at diagnosis: one receiving current prevention education and the other group receiving one-on-one prevention education and counseling with the physician and pediatric dental resident. Physician and pediatric dental resident will use motivational interviewing informed techniques during counseling. A caries risk assessment will be performed for each patient at diagnosis. Caries incidence, plaque scores, mutans streptococci levels, salivary flow rate, and salivary pH will be assessed at week one (diagnosis), week 16 or start of interim maintenance therapy whichever comes second, week 32 or beginning of maintenance therapy whichever is later for all patients enrolled in the study. Data will be collected through a clinical intraoral examination and salivary sample. Data collected will be used to assess the effect of increased prevention education on factors of importance in caries formation.

Interventions

Undergo dental examination

OTHEREducational Intervention (prevention education)

Receive prevention education

OTHERInterview

Ancillary studies

OTHERSurvey Administration

Ancillary studies

OTHEREducational Intervention (one-on one education)

Receive one-on-one education

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Virginia Commonwealth University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Pediatric patients who have been recently diagnosed with leukemia * Patients will also predictably be in primary or mixed dentition * Patients of Virginia Commonwealth University Medical Center Pediatric Hematology Oncology Clinic

Exclusion criteria

* Full permanent dentition * Primary language is not English * Children in the custody of the state with no parent or legal guardian present to sign consent

Design outcomes

Primary

MeasureTime frameDescription
Change in caries assessed by CAMBRA risk assessment toolBaseline up to 32 weeks
Change in salivary flow rateBaseline up to 32 weeksChange in salivary flow rate will be measured utilizing pre-weighed cotton rolls. Patients will saturate as many cotton rolls as possible in one minute by chewing. Dose cups and cotton rolls will be weighed prior to and after data collection. The change in weight in grams will be converted to mL of saliva collected.
Change in salivary pHBaseline up to 32 weeksWill be measured with litmus paper in the gingival sulcus of the tooth where plaque is collected for bacterial load testing.
Change in levels of mutans streptococci in buccal surface of most posterior maxillary right toothBaseline up to 32 weeksSamples will be plated on mitis salivarius and incubated. Mutans streptococci colonies will be counted after incubation.
Change in caries assessed by Merged International Caries Detection and Assessment System (ICDAS)Baseline up to 32 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026